Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC Protein Degrader ARV-471 Read more
FDA Approves KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma Read more
LEXEO Therapeutics Expands Cardiac Gene Therapy Pipeline with Acquisition of Stelios Therapeutics and its Gene Therapy Programs for Rare Cardiovascular Diseases Read more
Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa Read more
FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes Read more
Takeda Expands Moderna’s COVID-19 Vaccine Supply in Japan in Partnership with the Japanese Government Read more
Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to Novel Psilocybin and Derivates Program from Arbormentis LLC Read more